OrganiGram Holdings Stock (NASDAQ:OGI), Quotes and News Summary

Q: What sector and industry does OrganiGram Holdings (OGI) operate in?

OrganiGram Holdings is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NASDAQ.

OrganiGram Holdings Stock (NASDAQ: OGI) stock price, news, charts, stock research, profile.

Open	$1.750
Close	-
Volume / Avg.	1.210M / 1.570M
Day Range	1.750 - 1.920
52 Wk Range	0.970 - 2.910
Market Cap	$192.608M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	5.49%
Days to Cover	1.53

Recent News

Organigram Reports 262% Higher Quarterly Net Loss YoY, Makes Progress In International Markets

Nina Zdinjak

No Cannabis Tax Relief In Canada, Tilray CEO Says This 'Hinders Our Ability To Compete With The Illicit Market'

Nina Zdinjak

EXCLUSIVE: Fifteen New F1 Hybrid Cannabis Strains To Hit Shelves In US For 4/20 Under New Partnership

California-based I Love Growing Marijuana (ILGM), announced on Tuesday an exclusive new partnership with cannabis genetics and breeding company, Phylos Bioscience, that brings 15 new F1 hybrid strains to home growers across legal markets nationwide. ILGM is launching half the collection of strains that are "crafted for potency, flavor, and diversity" on its website just in time for marijuana culture's high holiday on 4/20. In doing so, the company is leveraging Phylos Bioscience's cutting-edge technology and extensive genetic library, which Benzinga has learned exclusively. Ernst Rustenhoven, CEO of ILGM, commented on the new partnership. "ILGM caters to a customer base of novice and veteran home growers on the hunt for increasingly unique strains of superior genetics, and we have been seeking an innovative partner to help elevate and diversify our product offerings," Rustenhoven said. "In forging a relationship with Phylos, we are taking our seed catalog to the next level with a highly curated selection of sought-after F1 hybrid strains."

Jelena Martinovic

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy OrganiGram Holdings (OGI) stock?

You can purchase shares of OrganiGram Holdings (NASDAQ: OGI) through any online brokerage.

View our list of the best stock brokerages.

Who are OrganiGram Holdings's (OGI) competitors?

There are no as such competitors for OrganiGram Holdings.

What is the target price for OrganiGram Holdings (OGI) stock?

The latest price target for OrganiGram Holdings (NASDAQ: OGI) was reported by Stifel on Monday, July 17, 2023. The analyst firm set a price target for 4.00 expecting OGI to rise to within 12 months (a possible 113.90% upside). 1 analyst firms have reported ratings in the last year.

Current Stock Price for OrganiGram Holdings (OGI)?

The stock price for OrganiGram Holdings (NASDAQ: OGI) is $1.87 last updated Today at May 14, 2024 at 11:34 AM EDT.

Does OrganiGram Holdings (OGI) pay a dividend?

There are no upcoming dividends for OrganiGram Holdings.

When is OrganiGram Holdings (NASDAQ:OGI) reporting earnings?

OrganiGram Holdings’s Q3 earnings are confirmed for Thursday, July 11, 2024.

Is OrganiGram Holdings (OGI) going to split?

There is no upcoming split for OrganiGram Holdings.

What sector and industry does OrganiGram Holdings (OGI) operate in?

OrganiGram Holdings is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NASDAQ.